Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Bain Capital in conjunction with acquisition of Diversey Care
Mandate

Vinge advises Bain Capital in conjunction with acquisition of Diversey Care

October 20, 2017 M&A

Vinge in its capacity as Swedish local counsel has advised Bain Capital in connection with the acquisition of Diversey Care.

Diversey is a leading supplier of, among other things, hygiene solutions for infection protection, kitchen hygiene and office cleaning.

Vinge’s team consisted of partners Christina Kokko (M&A), Fredrik Dahl (employment law), Louise Brorsson Salomon (banking & finance) and Albert Wållgren (banking & finance) as well as associates Alex Miler, Sara Strandberg, Louise Markgren, Josefine Lanker and Ludvig Wettergren.

Related

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its rights issue

 Vinge has advised Vicore Pharma Holding AB (publ) in connection with an oversubscribed rights issue of shares whereby Vicore receives issue proceeds of approximately SEK 782 million before deduction of transaction costs.
October 22, 2024

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its directed share issue

 Vinge has advised Vicore Pharma Holding AB (publ) in connection with a directed share issue, whereby Vicore receives issue proceeds of approximately SEK 100 million before deduction of transaction costs.
October 22, 2024

Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS

 Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS. The proceedings, which included considerations regarding state aid approved by the European Commission, have among other things involved restructuring, debt write-downs as well as an investment by a consortium consisting of Castlelake, Air France-KLM, Lind Invest and the Danish state. In total, the investment amounted to approximately USD 1.2 billion in SAS, divided into USD 475 million in unlisted equity and USD 725 million in convertible debt.
October 21, 2024